2926 - 2950 of 9104 Results
Title
Year
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 12
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
- Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting2020RESTRICTEDTitle: Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discountingJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 199Issue #:Start Page: 173070End Page: 173070Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2020.173070Citation Count: 10
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
-
OPENTitle: Review of the Effects of Lifestyle Modification on Parkinson’s DiseaseJournal Name: American Journal of Lifestyle MedicinePublisher: SAGE PublicationsVol:Issue #:Start Page: 15598276251384591End Page: 15598276251384591Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15598276251384591Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15598276251384591?download=trueCitation Count: 2
-
OPENTitle: Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndromeJournal Name: Journal of Neurodevelopmental DisordersPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s11689-025-09653-1Best OA location URL: https://jneurodevdisorders.biomedcentral.com/counter/pdf/10.1186/s11689-025-09653-1Citation Count: 3
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: http://orbilu.uni.lu/handle/10993/17148Citation Count: 82
- Oxidative Damage in Parkinson's Disease2005RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: SAGE PublicationsVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27
- Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease2016OPENTitle: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 89End Page: 94Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-161031Citation Count: 15
-
OPENTitle: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 4Start Page: 685End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171199Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199Citation Count: 20
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2889226Citation Count: 15
- Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation2020OPENTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/58956Citation Count: 12
-
OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8074509Citation Count: 13
- Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review2018RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
-
OPENTitle: Forecasts for the Attainment of Major Research Milestones in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1047End Page: 1055Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201933Best OA location URL: https://doi.org/10.17863/cam.52302Citation Count: 4
-
OPENTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3844End Page: 3855Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 2
-
OPENTitle: Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across AncestriesJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 9Start Page: 2015End Page: 2018Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30285Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30285Citation Count: 2
- Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation2020RESTRICTEDTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/58956-vCitation Count: 6
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13162155/Citation Count: 2
- PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)2020RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
OPENTitle: 0909 Pitolisant Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their OffspringJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A401Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0909Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468109/zsad077.0909.pdfCitation Count: 1
-
OPENTitle: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 1Start Page: e23011End Page: e23011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/23011Best OA location URL: https://jopm.jmir.org/2021/1/e23011/PDFCitation Count: 4
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978754Citation Count: 181